700 related articles for article (PubMed ID: 24997886)
21. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
[TBL] [Abstract][Full Text] [Related]
22. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
Vojta J; Jedlička A; Coufal P; Janečková L
J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.
Ram VR; Dave PN; Joshi HS
J Chromatogr Sci; 2012 Sep; 50(8):721-6. PubMed ID: 22641089
[TBL] [Abstract][Full Text] [Related]
24. HPTLC and RP-HPLC methods for simultaneous determination of Paracetamol and Pamabrom in presence of their potential impurities.
Abdelaleem EA; Naguib IA; Hassan ES; Ali NW
J Pharm Biomed Anal; 2015 Oct; 114():22-7. PubMed ID: 26001162
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a reversed phase liquid chromatographic method for analysis of oxytetracycline and related impurities.
Kahsay G; Shraim F; Villatte P; Rotger J; Cassus-Coussère C; Van Schepdael A; Hoogmartens J; Adams E
J Pharm Biomed Anal; 2013 Mar; 75():199-206. PubMed ID: 23277151
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
de Oliveira AM; Löwen TC; Cabral LM; dos Santos EM; Rodrigues CR; Castro HC; dos Santos TC
J Pharm Biomed Anal; 2005 Jul; 38(4):751-6. PubMed ID: 15967304
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations.
Emami J; Ghassami N; Ahmadi F
J Pharm Biomed Anal; 2006 Mar; 40(4):999-1005. PubMed ID: 16176866
[TBL] [Abstract][Full Text] [Related]
28. Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.
Gupta A; Ciavarella AB; Sayeed VA; Khan MA; Faustino PJ
J Pharm Biomed Anal; 2008 Jan; 46(1):181-6. PubMed ID: 17935923
[TBL] [Abstract][Full Text] [Related]
29. LC determination of glimepiride and its related impurities.
Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
[TBL] [Abstract][Full Text] [Related]
30. Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products.
Ciavarella AB; Gupta A; Sayeed VA; Khan MA; Faustino PJ
J Pharm Biomed Anal; 2007 Apr; 43(5):1647-53. PubMed ID: 17275240
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
Platzer DJ; White BA
J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
[TBL] [Abstract][Full Text] [Related]
32. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS
J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms.
Thumma S; Zhang SQ; Repka MA
Pharmazie; 2008 Aug; 63(8):562-7. PubMed ID: 18771002
[TBL] [Abstract][Full Text] [Related]
34. Stability-indicating LC-UV method for the determination of eszopiclone and degradation impurities in tablet dosage form.
Shaikh K; Patil A; Gite S
J Chromatogr Sci; 2014 Apr; 52(4):293-7. PubMed ID: 23552846
[TBL] [Abstract][Full Text] [Related]
35. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
Reddy PS; Sudhakar Babu K; Kumar N
J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a reversed phase liquid chromatographic method for analysis of griseofulvin and impurities.
Kahsay G; Adegoke AO; Van Schepdael A; Adams E
J Pharm Biomed Anal; 2013 Jun; 80():9-17. PubMed ID: 23518305
[TBL] [Abstract][Full Text] [Related]
38. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
[TBL] [Abstract][Full Text] [Related]
39. The determination of Miconazole and its related production impurities together with basic solution stability studies using a sub 2 μm chromatographic column.
O'Connor N; Geary M; Wharton M; Sweetman P
J Chromatogr Sci; 2012 Mar; 50(3):199-205. PubMed ID: 22337796
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a systematic UPLC-MS/MS method for simultaneous determination of three phenol impurities in ritonavir.
Venugopal N; Vijaya Bhaskar Reddy A; Madhavi G
J Pharm Biomed Anal; 2014 Mar; 90():127-33. PubMed ID: 24366213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
